Vol 11, Supplement 15 (September 29, 2019): Journal of Thoracic Disease


Impact of performance status and age on osimertinib efficacy in patients with EGFR-mutant T790M-positive non-small-cell lung cancer
Giuseppe Lamberti, Elisa Andrini, Biagio Ricciuti
PDA clipping by video-assisted thoracoscopic surgery
Koh Takeuchi
Relationship between performance status or younger age and osimertinib therapy in T790M-positive NSCLC: are the available data convincing?
Umberto Malapelle, Antonio Rossi, Emilio Bria
Bridging the gap: how do we improve long-term survival of locally-advanced esophageal cancer patients?
Andrew E. Giles, Biniam Kidane
Respecting your elders: osimertinib demonstrates preferential activity in elderly patients with T790M positive non-small cell lung cancers
Hiromichi Ebi, Sosipatros Boikos, Anthony C. Faber
Impact of clinical features on the efficacy of osimertinib treatment in epidermal growth factor receptor mutant non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors due to T790M mutation
Chong-Kin Liam, Mau-Ern Poh, Yong-Sheng Liam
Does osimertinib treatment discriminate young patients?
Cheng Ji, Chongke Zhong, Shi-Yong Sun
Adjuvant chemotherapy for poor pathologic response after pre-operative chemoradiation in esophageal cancer: infeasible and illogical
Megan Greally, Geoffrey Y. Ku
Devil is in the detail—how to critically analyze studies designed to assess effectiveness of topical antibiotics in preventing sternal wound infections?
Michał Pasierski, Kamil Zieliński, Giuseppe Maria Raffa, Harold Lazar, Roberto Lorusso, Piotr Suwalski, Mariusz Kowalewski

Editorial Commentary

Autopsy and clinical discrepancies in patients undergoing extracorporeal membrane oxygenation: a case series—a step towards understanding “Why”?
Chadi Aludaat, Matthieu Sarsam, Fabien Doguet, Jean-Marc Baste
Randomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease
Paul Windisch, Matthias Guckenberger
Optimal postoperative surveillance strategy in patients undergoing neoadjuvant chemoradiotherapy followed by surgery for esophageal carcinoma
Kotaro Sugawara, Hiroharu Yamashita, Yasuyuki Seto
Hyperprogressive disease with immunotherapy: new directions
Sally C. M. Lau, Natasha B. Leighl
Spread through air spaces in non-small cell lung cancer
Yuka Kozuma, Gouji Toyokawa, Yuichi Yamada, Fumihiro Shoji, Koji Yamazaki, Yoshinao Oda, Sadanori Takeo
Is no drain after thoracoscopic major resection for cancer acceptable?
Katsuhiro Okuda, Katsuhiko Endo, Keisuke Yokota, Tsutomu Tatematsu, Ryoichi Nakanishi
Expanding the pool: the use of hepatitis C RNA positive organs in lung transplantation
Ernest G. Chan, Patrick G. Chan, Pablo G. Sanchez
Preoperative variables for predicting prolonged air leak following pulmonary resection
Yasushi Shintani, Soichiro Funaki, Naoko Ose, Takashi Kanou, Eriko Fukui, Masato Minami
Challenge for establishment of international benchmarks for complications associated with esophagectomy
Masaaki Iwatsuki, Naoya Yoshida, Hideo Baba
Safety of perioperative low dose aspirin therapy in major lung resection
Woo Sik Yu, Chang Young Lee
No drain policy for “ultimate” enhanced recovery after surgery
Takuro Miyazaki, Takeshi Nagayasu
Scar modification for polymorphic ventricular tachycardia and ventricular fibrillation: hope beyond trigger ablation?
Hongtao Liao, Roderick Tung
Blood tumor mutational burden: are we ready for clinical implementation?
Claude Van Campenhout, Bárbara Meléndez, Myriam Remmelink, Isabelle Salmon, Nicky D’Haene
Local consolidative therapy in metastatic non-small cell lung cancer
Gunj Patel, Balazs Halmos, Haiying Cheng, Nitin Ohri
Preoperative treatment of anemia—could an ultra-short-term multimodal approach be beneficial for patients undergoing lung surgery?
Sebastian Heinrich, Torsten Loop
Optimal lung cancer screening intervals following a negative low-dose computed tomography result
Monica E. Reyes, Matthew B. Schabath
The inadvertent compounding of misconceptions regarding the surgical treatment of atrial fibrillation in mitral valve patients
James L. Cox, Patrick M. McCarthy
Potential advantage of digital drainage systems using a low-suction approach after video-assisted thoracoscopic surgery lobectomy
Hiran C. Fernando
The prospective database on thymic epithelial tumours from the European Continent
Masatsugu Hamaji, So Miyahara, Hyun-Sung Lee, Bryan M. Burt
Increasing T stage is associated with the need for more extensive lymph node assessment in clinical stage I non-small cell lung cancer
Andrew Brownlee, Seth B. Krantz
What you do not know, you do not recognize…and you do not improve future patient care…particularly in extracorporeal life support (ECLS) patients
Roberto Lorusso, Domenico Corradi
Hybrid minimally invasive esophagectomy for esophageal cancer: less is more
Pieter Christiaan van der Sluis, Peter Philipp Grimminger, Richard van Hillegersberg, Jelle Piet-Hein Ruurda
Predicting spread through air spaces (STAS) preoperatively: can imaging help?
Rocio Perez Johnston, Katsura Emoto, Joseph Dux, William D. Travis, Prasad S. Adusumilli
Expanding the donor pool for lung transplantation using HCV-positive donors
Hrishikesh S. Kulkarni, Kevin M. Korenblat, Daniel Kreisel
Role of chest tube drainage in physical function after thoracoscopic lung resection
Pengfei Li, Shuangjiang Li, Guowei Che
Hybrid esophagectomy: the best of both worlds
Jonathan Cools-Lartigue, Lorenzo Ferri
Minimally invasive esophagectomy—behind patient-centered learning curves
Nikhil Panda, Christopher R. Morse
PEEP titration guided by transpulmonary pressure: lessons from a negative trial
Fernando Suarez-Sipmann, Carlos Ferrando, Jesús Villar
KEYNOTE-042 and the role for single agent pembrolizumab in patients with PD-L1 tumor proportion score 1–49%
Daniel Morgensztern
Transcatheter edge-to-edge mitral valve repair in functional mitral regurgitation: patient selection according to MITRA-FR and COAPT
Martin Orban, Christian Hagl, Jörg Hausleiter
Lactate guided resuscitation—nothing is more dangerous than conscientious foolishness
Paul E. Marik
A new approach to predicting risk for N2 disease in non-small cell lung cancer
Roy H. Decker, Justin D. Blasberg
Prolonged air leak after pulmonary lobectomy
Francesco Petrella, Lorenzo Spaggiari
What did the first meta-analysis of tumor spread through air spaces (STAS) bring to light?
Hironori Uruga, Takeshi Fujii, Atsushi Miyamoto, Takaya Hisashi
Prolonged air leaks after vats lobectomy: do we need another risk score?
Angelo Carretta
Radical consolidative treatments a hope for patients with oligometastatic non-small cell lung cancer
Marcelo F. Jimenez, Maria T. Gomez-Hernandez
Intratumoral lymph vessel invasion as a predictive risk factor for nodal metastasis in non-small cell lung cancer: should L-1 status obligate adjuvant chemotherapy?
Kimberly J. Song, Raja M. Flores
Demographic ageing and its influence on current lung transplant practice
Antonio Alvarez, Paula Moreno
Searching for an arrow hitting two targets: the time to evaluate long-term outcomes of video-assisted thoracoscopic surgery lobectomy for early-stage lung cancer
Tomohito Saito, Tomohiro Murakawa
Less is more: the benefits of low suction for digital pleural drainage devices after pulmonary resection
Stephen Donald Gowing, Virginia Ferreira Resende, Sebastien Gilbert
Importance of intraoperative fluid management
Hisashi Iwata
Thymoma: does tumor size matter?
Arya Amini, Chad G. Rusthoven
Expanding the knowledge of oligometastatic disease—but uncertainties remain significant
Joachim Pfannschmidt
Positive-end expiratory pressure titration and transpulmonary pressure: the EPVENT 2 trial
Emanuele Turbil, Louis Marie Galerneau, Nicolas Terzi, Carole Schwebel, Laurent Argaud, Claude Guérin
Pancreatic PCSK9 and its involvement in diabetes
Maaike Kockx, Leonard Kritharides
The radical approach to the oligometastatic not small cell lung cancer patient: which? how? when? where?
Luca Bertolaccini, Lorenzo Spaggiari

Letter to the Editor

Chest ultrasound: enhanced recovery after surgery (ERAS) best friend in general thoracic surgery
Marco Chiappetta, Amedeo Iaffaldano, Leonardo Petracca Ciavarella, Elisa Meacci, Stefano Margaritora
Is chest ultrasonography an essential tool for the modern thoracic surgeon?
Marco Chiappetta, Edoardo Zanfrini, Leonardo Petracca Ciavarella, Elisa Meacci, Stefano Margaritora
Chest ultrasound versatility in routinary to complicated cases: our perspective
Marco Chiappetta, Gianmaria Ferretti, Maria Teresa Congedo, Maria Letizia Vita, Stefano Margaritora
Sex differences in the development of upper airway morphology: is this the new kid on the block?
Ayako Inoshita, Takatoshi Kasai, Rina Matsuoka, Naoko Sata, Nanako Shiroshita, Fusae Kawana, Mitsue Kato, Katsuhisa Ikeda
Emphysema assessment for personalized immunotherapy response prediction in lung cancer patients
Dimitra Kerdidani, Sophia Magkouta, Maria Tsoumakidou
Albumin to fibrinogen ratio and fibrinogen to pre-albumin ratio are economical, simple and promising prognostic factors for solid malignancy
Shu-Qi Li, Xia-Hong You, Fan Sun, Zi-Jin Xia, Zhou Fang, Wei Wang, Yao Li, Xiao-Zhong Wang, Hou-Qun Ying
Chest ultrasound in post-operative management: the needed to rethink our perspective?
Marco Chiappetta, Luca Pogliani, Dania Nachira, Maria Letizia Vita, Stefano Margaritora
Pathologic complete response is not equivalent to cure in esophageal cancer
Rebecca Carr, Daniela Molena
Heterogeneity of stage IIIA leads to difficulty in determining optimal treatment
Min P. Kim, Stephen G. Swisher
The tightrope walk between temporary and permanent mechanical circulatory support
L. Christian Napp, Maximilian Halbe, Federico Pappalardo


The supplement was commissioned by the Editorial office, Journal of Thoracic Disease without any sponsorship or funding.